HOME >> BIOLOGY >> NEWS
AutovaxID-C introduced by Accentia Biopharmaceuticals

Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced that its subsidiary, Biovest International, Inc., presented its newest cell culture instrument, the AutovaxIDTM-C, at the Cancer Research Institute's recent meeting, "Cancer Vaccines: Barriers, Endpoints and Opportunities." This was the first introduction of the AutovaxID-C to the biotech industry.

The AutovaxID-C is an automated hollow fiber cell culture instrument that collects secreted protein from cells and controls the growth of the cells automatically for 30 days or more. Growth takes place in sterile, disposable patient specific modules that are bar coded for ease of tracking and identification. Biovest believes that the AutovaxID-C instrument represents a significant advance in personalized medicine because it reduces the possibility of cross contamination and allows segregation of patient specific vaccine batches. Further expected advantages include reduced manpower requirements, automated batch record generation and improved efficiency in facility design.

"Cancer vaccines are one of the most exciting and promising fields of personalized medicine," said Carl M. Cohen, Ph.D., Chief Operating Officer, Biovest. "The production of a patient specific vaccine to immunize individuals against their own cancers has been a goal of investigators in both academia and industry. Biovest is currently testing an idiotype vaccine to treat follicular non-Hodgkin's lymphomas in a Phase 3 clinical trial."

"Our approach is unique in that it uses hybridoma technology to produce complete idiotype proteins identical to those on the tumor B cells. Results from early clinical trials are very encouraging and generating a lot of excitement in the medical community; however, there has been some concern about the challenge of producing personalized vaccines on a large scale. At this meeting we presented the first of a suite of instruments, designed and produced by the Biovest Advanced Inst
'"/>

Contact: Sherran Brewer
sbrewer@accentia.net
866-481-9020
SciWords
8-Dec-2005


Page: 1 2 3

Related biology news :

1. AutovaxID-C introduced by Biovest International
2. First SCID gene chip to be introduced at Academy meeting on immunodeficiencies
3. Ape computers introduced in the US
4. FDA grants Accentia Biopharmaceuticals...
5. Accentia Biopharmaceuticals announces option agreement with Mayo
6. Accentia Biopharmaceuticals acquires exclusive license
7. Accentia Biopharmaceuticals, Inc. launches CRSFungal Profile

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... TORONTO (PRWEB) , ... January 17, 2019 , ... ... with regards to drug metabolism and distribution has been documented for many years. ... dosages, or in terms of adverse event profiles in patients residing in different ...
(Date:1/14/2019)... ... 14, 2019 , ... CellMax Life , a diagnostics ... will present new findings at the ASCO Gastrointestinal Cancer Symposium in San Francisco ... from this study show CellMax Life’s blood test, based on its proprietary CMxTM ...
(Date:1/10/2019)... ... 09, 2019 , ... Dr. Beanlands is the Vered Chair and Division Head ... He is also Director of its National Cardiac PET Centre, and Professor in the ... and in the Department of Cellular and Molecular medicine. , He is a founding ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... (PRWEB) , ... January 30, 2019 , ... ... section of the international tasting 5StarWines to promote and give recognition to producers ... The Wine Without Walls selection takes place in Verona, Italy, contemporaneously to the ...
(Date:1/24/2019)... ... January 22, 2019 , ... Dr. Douglas Stramel of ... Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly three years. A ... Cell Therapy since 2007 and began using V-PET™ 2016. V-PET™ is a ...
(Date:1/21/2019)... ... January 21, 2019 , ... ... product line, SporActiv™, for the industrial and institutional cleaning market. MDG’s SporActiv liquid ... and commercial cleaning needs. Applications include odor control, floor and tile cleaners, carpets, ...
(Date:1/20/2019)... ... ... The American Society of Gene & Cell Therapy (ASGCT) is proud to announce the ... Designed by ASGCT committee volunteers in coordination with patient advocacy groups, the new patient-centered ... status and promise of gene and cell therapies. , Gene Therapy 101 , ...
Breaking Biology Technology:
Cached News: